Viewing Study NCT05847660



Ignite Creation Date: 2024-05-06 @ 6:58 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05847660
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-05-06
First Post: 2023-04-27

Brief Title: Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient
Sponsor: Fayoum University
Organization: Fayoum University

Study Overview

Official Title: A Randomized Controlled Study of Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patients in Intracytoplasmic Sperm Injection Cycles
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: this study is designed to compare the Progesterone primed ovarian stimulation protocol versus the antagonist protocol as a method to stimulate PCO patients in ICSI cycles to decrease cost and decrease OHSS
Detailed Description: A Randomized controlled non-blinded study parallel-group study with 11 randomization will be conducted at a Specialized Authorized IVF unit starting from January 2023 till completing the sample size Randomization will be generated by a computer and held with one of the experimenters and n of the black and red cards will be used for allocation concealment

Participants All PCO patients will be given informed consent about the study aims and written consent will be taken at the first visit to the infertility clinic of the Specialized Authorized IVF unit

Patients will be categorized as Group A Progesterone primed ovarian stimulation protocol Group B conventional antagonist protocol

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None